The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries
Open accessAbstract
OBJECTIVE: To assess human papillomavirus (HPV) vaccination coverage after demonstration projects conducted in India, Peru, Uganda and Viet Nam by PATH and national governments and to explore the reasons for vaccine acceptance or refusal. METHODS: Vaccines were delivered through schools or health centres or in combination with other health interventions, and either monthly or through campaigns at fixed time points. Using a two-stage cluster sample design, the authors selected households in demonstration project areas and interviewed over 7000 parents or guardians of adolescent girls to assess coverage and acceptability. They defined full vaccination as the receipt of all three vaccine doses and used an open-ended question to explore acceptability. FINDINGS: Vaccination coverage in school-based programmes was 82.6% (95% confidence interval, CI: 79.3-85.6) in Peru, 88.9% (95% CI: 84.7-92.4) in 2009 in Uganda and 96.1% (95% CI: 93.0-97.8) in 2009 in Viet Nam. In India, a campaign approach achieved 77.2% (95% CI: 72.4-81.6) to 87.8% (95% CI: 84.3-91.3) coverage, whereas monthly delivery achieved 68.4% (95% CI: 63.4-73.4) to 83.3% (95% CI: 79.3-87.3) coverage. More than two thirds of respondents gave as reasons for accepting the HPV vaccine that: (i) it protects against cervical cancer; (ii) it prevents disease, or (iii) vaccines are good. Refusal was more often driven by programmatic considerations (e.g. school absenteeism) than by opposition to the vaccine. CONCLUSION: High coverage with HPV vaccine among young adolescent girls was achieved through various delivery strategies in the developing countries studied. Reinforcing positive motivators for vaccine acceptance is likely to facilitate uptake.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Human papillomavirus vaccines: WHO position paper
WHO (2009) · Biologicals · doi:10.1016/j.biologicals.2009.04.005 · Cited by 357
Lim, S. S., Stein, D. B., Charrow, A., & Murray, C. J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61869-3 · Cited by 294
Dorell, C., Stokley, S. K., Yankey, D., Cohn, A. C., & Markowitz, L. E. (2010) · MMWR Morbidity and Mortality Weekly Report · Cited by 289
Global Routine Vaccination Coverage — 2017
VanderEnde, K., Gacic-Dobo, M., Diallo, M. S., Conklin, L. M., & Wallace, A. S. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6745a2 · Cited by 265
Ogilvie, G., Anderson, M., Marra, F., McNeil, S., Pielak, K., Dawar, M., McIvor, M., Ehlen, T., Dobson, S., Money, D., et al. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000270 · Cited by 229
Brabin, L., Roberts, S. A., Stretch, R., Baxter, D., Chambers, G., Kitchener, H., & McCann, R. (2008) · BMJ · doi:10.1136/bmj.39541.534109.be · Cited by 209
Chapter 24: Psychosocial aspects of vaccine acceptability
Zimet, G. D., Liddon, N., Rosenthal, S. L., Lazcano-Ponce, E., & Allen, B. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.06.017 · Cited by 208
Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries
Goldie, S. J., O'Shea, M., Campos, N. G., Diaz, M., Sweet, S., & Kim, S.-Y. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.04.053 · Cited by 197
Insinga, R. P., Dasbach, E. J., & Elbasha, E. H. (2005) · PharmacoEconomics · doi:10.2165/00019053-200523110-00004 · Cited by 195
(2009) · PubMed · Cited by 187
Parental Attitudes About Sexually Transmitted Infection Vaccination for Their Adolescent Children
Zimet, G. D., Mays, R. M., Sturm, L. A., Ravert, A. A., Perkins, S. M., & Juliar, B. E. (2005) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.159.2.132 · Cited by 175
Stokley, S. K., Dorell, C., & Yankey, D. (2009) · MMWR Morbidity and Mortality Weekly Report · Cited by 174
Mathew, A., & George, P. S. (2009) · PubMed · Cited by 156
A systematic review of measures used in studies of human papillomavirus (HPV) vaccine acceptability
Allen, J. D., Coronado, G. D., Williams, R. S., Glenn, B. A., Escoffery, C., Fernández, M. E., Tuff, R. A., Wilson, K. M., & Mullen, P. D. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.03.063 · Cited by 143
Parental acceptance of Human Papillomavirus vaccines
Lenselink, C. H., Gerrits, M. M. J. G., Melchers, W. J. G., Massuger, L. F. A. G., van Hamont, D., & Bekkers, R. L. M. (2007) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2007.02.012 · Cited by 128
Global Routine Vaccination Coverage, 2015
Casey, R. M., Dumolard, L. B., Danovaro-Holliday, M. C., Gacic-Dobo, M., Diallo, M., Hampton, L. M., & Wallace, A. S. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6545a5 · Cited by 114
Prospects and prejudices of human papillomavirus vaccines in India
Das, B. C., Hussain, S., Nasare, V. D., & Bharadwaj, M. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.03.056 · Cited by 112
Attitudes toward HPV vaccination among parents of adolescent girls in Mysore, India
Madhivanan, P., Krupp, K., Yashodha, M. N., Marlow, L., Klausner, J. D., & Reingold, A. L. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.06.073 · Cited by 98
Effects of Information Framing on Human Papillomavirus Vaccination
Leader, A. E., Weiner, J. L., Kelly, B., Hornik, R., & Cappella, J. N. (2009) · Journal of Women s Health · doi:10.1089/jwh.2007.0711 · Cited by 98
Costs of detection and treatment of cervical cancer, cervical dysplasia and genital warts in the UK
Brown, R. E., Breugelmans, J. G., Theodoratou, D., & Bénard, S. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x99972 · Cited by 90
Human papillomavirus vaccines. WHO position paper.
(2009) · PubMed · Cited by 90
HPV vaccine acceptability among Kenyan women
Becker‐Dreps, S., Otieno, W. A., Brewer, N. T., Agot, K. E., & Smith, J. S. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.05.034 · Cited by 87
Watson, M., Shaw, D. D., Molchanoff, L., & McInnes, C. (2009) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1753-6405.2009.00409.x · Cited by 82
HPV & HPV vaccination: issues in developing countries.
Bharadwaj, M., Hussain, S., Nasare, V. D., & Das, B. C. (2009) · PubMed · Cited by 75
An assessment of the readiness for introduction of the HPV vaccine in Uganda.
Katahoire, R. A., Jitta, J., Kivumbi, G., Murokora, D., Arube, W. J., Siu, G., Arinaitwe, L., Bingham, A., Mugisha, E. J., Tsu, V. D., et al. (2008) · PubMed · Cited by 68
Self-citationPreparing for the introduction of HPV vaccines: policy and programme guidance for countries.
Broutet, N. J. N., Huntington, D., Cutts, F. T., & Hall, P. S. (2006) · Cited by 66
Current issues in adolescent immunization
Brabin, L., Greenberg, D. P., Hessel, L., Hyer, R. N., Ivanoff, B., & Damme, P. V. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.04.055 · Cited by 58
Penny, M. E., Bartolini, R. M., Mosqueira, N. R., LaMontagne, D. S., Mendoza, M. A., Ramos, I. N., Winkler, J. L., Villafana, J., Janmohamed, A., & Jumaan, A. O. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.04.078 · Cited by 42
Self-citationCervical cancer prevention and the Millennium Development Goals
Wittet, S. (2008) · Bulletin of the World Health Organization · doi:10.2471/blt.07.050450 · Cited by 39
Human papillomavirus vaccine introduction in Vietnam: formative research findings
Nghi, N. Q., LaMontagne, D. S., Bingham, A., Rafiq, M., Phượng, L. T., Lien, N. T. P., Nguyen, K. C., Hồng, D. T., Huyen, D. T. T., Tho, N. T. T., et al. (2010) · Sexual Health · doi:10.1071/sh09123 · Cited by 38
Self-citationAn Approach to Formative Research in HPV Vaccine Introduction Planning in Low-Resource Settings
Bingham, A., Janmohamed, A., Bartolini, R. M., Creed‐Kanashiro, H., Katahoire, Y. R., Khan, I., Lyazi, I., Menezes, L., Murokora, D., Nguyen, N. Q., et al. (2009) · The Open Vaccine Journal · doi:10.2174/1875035400902010001 · Cited by 31
Self-citationJacob, M., Mawar, N., Menezes, L., Kaipilyawar, S., Gandhi, S., Khan, I., Patki, M., Bingham, A., LaMontagne, D. S., Bagul, R., et al. (2010) · The Open Vaccine Journal · doi:10.2174/1875035401003010096 · Cited by 29
Self-citationFerris, D. G., Cromwell, L., Waller, J. L., & Horn, L. (2010) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e3181d41806 · Cited by 28
Luciani, S., Jaúregui, B., Kieny, C., & Andrus, J. K. (2009) · Immunotherapy · doi:10.2217/imt.09.48 · Cited by 19
New paradigm for prevention of cervical cancer
Kaufmann, A. M., & Schneider, A. (2006) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2006.07.048 · Cited by 14
Cited by
Strategies for addressing vaccine hesitancy–A systematic review
Jarrett, C., Wilson, R., O’Leary, M., Eckersberger, E., & Larson, H. J. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.04.040 · Cited by 1,066
Bruni, L., Diaz, M., Barrionuevo-Rosas, L., Herrero, R., Bray, F., Bosch, F. X., de Sanjosé, S., & Castellsagué, X. (2016) · The Lancet Global Health · doi:10.1016/s2214-109x(16)30099-7 · Cited by 824
Barriers to vaccination in Latin America: A systematic literature review
Guzman-Holst, A., DeAntonio, R., Prado-Cohrs, D., & Juliao, P. (2020) · Vaccine · doi:10.1016/j.vaccine.2019.10.088 · Cited by 594
Human Papillomavirus Vaccine Introduction – The First Five Years
Markowitz, L. E., Tsu, V., Deeks, S. L., Cubie, H., Wang, S. A., Vicari, A. S., & Brotherton, J. M. L. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.05.039 · Cited by 364
Human Papillomavirus Vaccines: An Updated Review
Cheng, L., Wang, Y., & Du, J. (2020) · Vaccines · doi:10.3390/vaccines8030391 · Cited by 329
Metadata
- Authors
- LaMontagne, D. S., Barge, S., Le, N. T., Mugisha, E., Penny, M., Gandhi, S., Janmohamed, A., Kumakech, E., Mosqueira, N. R., Nguyen, N. Q., Paul, P., Tang, Y., Minh, T. H., Uttekar, B. P., & Jumaan, A.
- Venue
- Bulletin of the World Health Organization
- Publisher
- WHO Press
- Published
- 2011-11-01
- Volume
- 89
- Issue
- 11
- Pages
- 821-830
- ISSN
- 0042-9686 (ISSN-L)
- OpenAlex
- W2140942388
- Cited by
- 271
- References
- 36
- FWCI
- 15.99
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.